Dasotraline Pediatric Extension Study

Clinical trial NCT02457819 · COMPLETED

Trial details

NCT number: NCT02457819
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2015-06-30
Primary completion: 2017-02-02
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.